Fluorescence in situ hybridization monitoring of BCR-ABL-positive neutrophils in chronic-phase chronic myeloid leukemia patients during the primary stage of imatinib mesylate therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/15814334

Download in:

View as

General Info

PMID
15814334